FERNANDO SANCHEZ-BRUGAL: Open Payments
NPI 1720026974 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 36 payments from 5 companies in 2025. Trend: 2023 $535 · 2024 $845 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $368 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Novo Nordisk Inc | 2 | $33 |
| Lilly USA, LLC | 1 | $19 |
| Viatris Specialty LLC | 1 | $15 |
Products named: QULIPTA, UBRELVY, VRAYLAR, ZENPEP, MOUNJARO, Wegovy, YUPELRI, Ozempic.
Industry payments across NC — which companies pay providers there.
